JAMDA
Volume 9, Issue 1 , Pages 51-54 , January 2008

Prevalence of a Hemoglobin A1c Less Than 7.0%, of a Blood Pressure Less Than 130/80 mm Hg, and of a Serum Low-Density Lipoprotein Cholesterol Less Than 100 mg/dL in Older Patients With Diabetes Mellitus in an Academic Nursing Home

References 

  1. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care. 2003;26(supplement 1):533–550
  2. Smith SC, Allen J, Blair SN, et al. ACC/AHA guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: Endorsed by the National Heart, Lung, and Blood Institute. Circulation. 2006;113:2363–2372
  3. Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study. Brit Med J. 2000;321:405–412
  4. Ravipati G, Aronow WS, Ahn C, et al. Association of hemoglobin A1c level with the severity of coronary artery disease in patients with diabetes mellitus. Am J Cardiol. 2006;97:968–969
  5. Aronow WS, Ahn C, Weiss MB, Babu S. Relation of hemoglobin A1c levels to severity of peripheral arterial disease in patients with diabetes mellitus. Am J Cardiol. 2007;99:1468–1469
  6. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (The JNC 7 Report). JAMA. 2003;289:2560–2572
  7. Adler AI, Stratton IM, Neil HAW, et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): Prospective observational study. Brit Med J. 2000;321:412–419
  8. Aronow WS. Drug therapy of older persons with hypertension. J Am Med Dir Assoc. 2006;7:193–196
  9. Koka M, Joseph J, Aronow WS. Adequacy of control of hypertension in an academic nursing home. J Am Med Dir Assoc. 2007;8:538–540
  10. Ziesmer V, Ghosh S, Aronow WS. Use of antihypertensive drug therapy in older persons in an academic nursing home. J Am Med Dir Assoc. 2002;3:243–245
  11. Grundy SM, Cleeman JI, Merz CNB, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004;110:227–239
  12. Aronow WS. Updated National Cholesterol Education Program III guidelines. J Am Med Dir Assoc. 2005;6:160–161
  13. Zarowitz BJ, Aronow WS, Hollenack K, O’Shea T. The application of evidence-based principles of care in older persons (issue 2): Management of lipid disorders. J Am Med Dir Assoc. 2006;7:173–179
  14. Aronow WS. Managing hyperlipidaemia in the elderly (Special considerations for a population at high risk). Drugs Aging. 2006;23:181–189
  15. Koka M, Joseph J, Aronow WS. Prevalence of adequate and of optimal control of serum low-density lipoprotein cholesterol in an academic nursing home. J Am Med Dir Assoc. 2007;8:604–606
  16. Ghosh S, Aronow WS. Utilization of lipid-lowering drugs in elderly persons with increased serum low-density lipoprotein cholesterol associated with coronary artery disease, symptomatic peripheral arterial disease, prior stroke, or diabetes mellitus before and after an educational program on dyslipidemia treatment. J Gerontol A Biol Sci Med Sci. 2003;58A:M432–M435
  17. National Kidney Foundation Guideline. K/DOQI clinical practice guidelines for chronic kidney disease: Kidney Disease Outcome Quality Initiative. Am J Kidney Dis. 2002;39(suppl 2):S1–S246
  18. American Diabetes Association. Treatment of hypertension of adults with diabetes. Diabetes Care. 2003;26(suppl 1):580–582
  19. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann Intern Med. 1999;130:461–470
  20. Mooradian AD, Osterweil D, Petrasek D, Morley JE. Diabetes mellitus in elderly nursing home patients (A survey of clinical chartacteristics and management). J Am Geriatr Soc. 1988;36:391–396
  21. Alam T, Weintraub N, Weinreb J. What is the proper use of hemoglobin A1c monitoring in the elderly?. J Am Med Dir Assoc. 2006;7(suppl 3):S60–S64
  22. Martin-Baranera M, Sanchez Ferrin P, Armario P Geriatric HTA Study Group. Prevalence of hypertension in elderly long-term care residents in Spain (The Geriatric HTA study). Medicina Clinica. 2006;127:681–687
  23. Thomas JM, Alvarez W, Mulaj M, et al. Control of hypertension in nursing homes. Revue Medicale de Bruxelles. 2006;27:S271–S273
  24. Aronow WS, Ahn C. Incidence of new coronary events in older persons with prior myocardial infarction and serum low-density lipoprotein cholesterol ≥125 mg/dL treated with statins versus no lipid-lowering drug. Am J Cardiol. 2002;89:67–69
  25. Aronow WS, Ahn C, Gutstein H. Incidence of new atherothrombotic brain infarction in older persons with prior myocardial infarction and serum low-density lipoprotein cholesterol ≥125 mg/dL treated with statins versus no lipid-lowering drug. J Gerontol A Biol Sci Med Sci. 2002;57A:M333–M335
  26. Aronow WS, Ahn C, Gutstein H. Reduction of new coronary events and of new atherothrombotic brain infarction in older persons with diabetes mellitus, prior myocardial infarction, and serum low-density lipoprotein cholesterol ≥125 mg/dL treated with statins. J Gerontol A Biol Sci Med Sci. 2002;57A:M747–M750

 None of the authors have any conflicts of interest pertaining to this study.

PII: S1525-8610(07)00393-3

doi: 10.1016/j.jamda.2007.08.012

JAMDA
Volume 9, Issue 1 , Pages 51-54 , January 2008

Article Tools